Mitochondrial Dysfunction in Type 2 Diabetes and Obesity

被引:121
作者
Hojlund, Kurt [1 ]
Mogensen, Martin [2 ]
Sahlin, Kent [2 ,3 ]
Beck-Nielsen, Henning [1 ]
机构
[1] Odense Univ Hosp, Dept Endocrinol, Diabet Res Ctr, DK-5000 Odense C, Denmark
[2] Univ So Denmark, Inst Sports Sci & Clin Biomech, DK-5230 Odense, Denmark
[3] GIH, Swedish Sch Sport & Hlth Sci, S-11486 Stockholm, Sweden
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.ecl.2008.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance in skeletal muscle is a major hallmark of type 2 diabetes mellitus (T2D) and obesity that is characterized by impaired insulin-mediated glucose transport and glycogen synthesis and by increased intramyocellular content of lipid metabolites. Several studies have provided evidence for mitochondrial dysfunction in skeletal muscle of type 2 diabetic and prediabetic subjects, primarily due to a lower content of mitochondria (mitochondrial biogenesis) and possibly to a reduced functional capacity per mitochondrion. This article discusses the latest advances in the understanding of the molecular mechanisms underlying insulin resistance in human skeletal muscle in T2D and obesity, with a focus on possible links between insulin resistance and mitochondrial dysfunction.
引用
收藏
页码:713 / +
页数:20
相关论文
共 101 条
[1]   Ceramide content is increased in skeletal muscle from obese insulin-resistant humans [J].
Adams, JM ;
Pratipanawatr, T ;
Berria, R ;
Wang, E ;
DeFronzo, RA ;
Sullards, MC ;
Mandarino, LJ .
DIABETES, 2004, 53 (01) :25-31
[2]   Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients [J].
Anello, M ;
Lupi, R ;
Spampinato, D ;
Piro, S ;
Masini, M ;
Boggi, U ;
Del Prato, S ;
Rabuazzo, AM ;
Purrello, F ;
Marchetti, P .
DIABETOLOGIA, 2005, 48 (02) :282-289
[3]   Proteomic analysis of pharmacological preconditioning -: Novel protein targets converge to mitochondrial metabolism pathways [J].
Arrell, D. Kent ;
Elliott, Steven T. ;
Kane, Lesley A. ;
Guo, Yurong ;
Ko, Young H. ;
Pedersen, Pete L. ;
Robinson, John ;
Murata, Mitsushige ;
Murphy, Anne M. ;
Marban, Eduardo ;
Van Eyk, Jennifer E. .
CIRCULATION RESEARCH, 2006, 99 (07) :706-714
[4]   Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects [J].
Bandyopadhyay, Gautam K. ;
Yu, Joseph G. ;
Ofrecio, Jachelle ;
Olefsky, Jerrold M. .
DIABETES, 2006, 55 (08) :2277-2285
[5]   Skeletal muscle mitochondrial protein metabolism and function in ageing and type 2 diabetes [J].
Barazzoni, R .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (01) :97-102
[6]   Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects - experiences from relatives and twin studies [J].
Beck-Nielsen, H ;
Vaag, A ;
Poulsen, P ;
Gaster, M .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 17 (03) :445-467
[7]   Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients [J].
Befroy, Douglas E. ;
Petersen, Kitt Falk ;
Dufour, Sylvie ;
Mason, Graeme F. ;
de Graaf, Robin A. ;
Rothman, Douglas L. ;
Shulman, Gerald I. .
DIABETES, 2007, 56 (05) :1376-1381
[8]   Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis [J].
Bergeron, R ;
Ren, JM ;
Cadman, KS ;
Moore, IK ;
Perret, P ;
Pypaert, M ;
Young, LH ;
Semenkovich, CF ;
Shulman, GI .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (06) :E1340-E1346
[9]   Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation [J].
Bijur, GN ;
Jope, RS .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (06) :1427-1435
[10]   Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation [J].
Bjornholm, M ;
Kawano, Y ;
Lehtihet, M ;
Zierath, JR .
DIABETES, 1997, 46 (03) :524-527